The Latest
-
Apple ordered to pay Masimo $184M in interest on patent damages
A U.S. district court ruled that Apple owes prejudgment interest on the $634 million in damages it incurred for infringing Masimo’s pulse oximetry patent.
-
UK backs continuous oversight of AI medical devices
The Medicines and Healthcare Products Regulatory Agency adopted 44 recommendations, including a call for AI-enabled devices to be monitored throughout their working life.
-
Stryker CEO Kevin Lobo to resign
Lobo will step down on Dec. 31 as CEO after more than 15 years at Stryker. Chief operating officer Spencer Stiles will lead the company.
-
Abbott gets FDA nod for updates to heart failure monitoring system
Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.
-
BD strikes supply chain pact with Trump administration
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
-
Top medtech conferences in 2027
From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.
-
Zenflow raises $52M, inks distribution deal with Cook Medical
Cook Medical has become Zenflow’s U.S. distributor in a urology device market targeted by Boston Scientific, Olympus and Teleflex.
-
Q&A
After years-long turnaround, Convatec’s new CEO plans R&D push
Jonny Mason, who became CEO of the medtech firm a year ago following the death of Karim Bitar, said Convatec’s pace of launching new devices has accelerated for 2026 and 2027.
-
GE HealthCare to acquire Sofie Biosciences for $945M
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
-
ARPA-H awards more than $100M to biosensor development projects
Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.
-
Retrieved from Michigan Medicine on October 02, 2026
Edwards’ adjustable heart valve for children lands FDA approval
The device could help young patients avoid multiple open-heart surgeries as they grow, FDA officials said.
-
FDA to prioritize guidance on AI, surgical robots next year
The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.
-
Medtronic drug-coated balloon gets FDA breakthrough status
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
-
Data privacy concerns could hold patients back from using AI
Although artificial intelligence has quickly become integrated into our daily lives, Americans say they’re becoming increasingly concerned about their health data.
-
FDA selects first 5 participants for READI-Home initiative
The innovation challenge is focused on developing home devices that could help reduce hospital readmissions.
-
Medtronic reveals cardiac mapping and ablation software clearances
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.
-
Abbott launches Freenome’s colorectal cancer screening test
Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.
-
GE HealthCare hires new global chief AI officer
Rodolphe Katra has joined from Medtronic to lead GE HealthCare’s efforts to connect devices, software and data.
-
Oura delays IPO
Citing market uncertainty, the smart ring maker plans to delay a public offering that it had expected to raise up to $2.2 billion.
-
US-China trade board carves path for tariff relief on $60B of goods
The board has proposed lower tariffs on U.S.-bound household goods and toys, but the White House did not specify reduction amounts or an implementation date.
-
Sofinnova raises 82M euros to fund medtech startups
The venture capital firm expects to launch up to eight new medtech ventures over the next five years.
-
Carlsmed names new CFO
Former ZimVie CFO Richard Heppenstall fills the vacancy created by the departure of Leo Greenstein, who is leaving Carlsmed to pursue other professional interests.
-
Intuitive expands push into cardiac market with CE mark
After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.
-
FDA issues draft guidance for surgical robots
A two-day public workshop on evaluating robotic surgery systems with autonomous or remote capabilities is also on the agency’s agenda, as telesurgery advances globally.
-
GE HealthCare to explore applying generative AI to radiation therapy workflows
The company has teamed up with a Mass General Brigham research team to help care teams access patient-specific information.